statistiche ricercatore

Continente	#
EU - Europa	1.291
NA - Nord America	1.099
AS - Asia	478
SA - Sud America	90
AF - Africa	30
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.992

Nazione	#
US - Stati Uniti d'America	1.077
IT - Italia	383
RU - Federazione Russa	292
DE - Germania	185
SG - Singapore	140
CN - Cina	117
IE - Irlanda	105
FI - Finlandia	104
BR - Brasile	81
VN - Vietnam	66
GB - Regno Unito	52
FR - Francia	48
HK - Hong Kong	40
KR - Corea	32
SE - Svezia	28
NL - Olanda	20
BE - Belgio	17
IN - India	16
ES - Italia	13
CA - Canada	12
ZA - Sudafrica	12
JP - Giappone	11
BD - Bangladesh	10
IQ - Iraq	10
CZ - Repubblica Ceca	9
PL - Polonia	8
CH - Svizzera	6
TR - Turchia	6
UA - Ucraina	6
AR - Argentina	5
CI - Costa d'Avorio	5
IR - Iran	5
MX - Messico	5
AT - Austria	4
HN - Honduras	3
ID - Indonesia	3
KZ - Kazakistan	3
MY - Malesia	3
NG - Nigeria	3
SA - Arabia Saudita	3
UZ - Uzbekistan	3
VE - Venezuela	3
AU - Australia	2
AZ - Azerbaigian	2
DZ - Algeria	2
EE - Estonia	2
KE - Kenya	2
MA - Marocco	2
TN - Tunisia	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BY - Bielorussia	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
EG - Egitto	1
GE - Georgia	1
HR - Croazia	1
IL - Israele	1
KG - Kirghizistan	1
LK - Sri Lanka	1
LT - Lituania	1
LV - Lettonia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
PK - Pakistan	1
PT - Portogallo	1
RS - Serbia	1
TH - Thailandia	1
XK - ???statistics.table.value.countryCode.XK???	1
YE - Yemen	1
ZW - Zimbabwe	1
Totale	2.992

Nome	#
A first update on mapping the human genetic architecture of COVID-19	574
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study	499
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males	386
An explainable model of host genetic interactions linked to COVID-19 severity	364
Genome editing for clinically relevant mutations in genetic diseases and cancer	255
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age	251
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot	231
Correction: New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells	178
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot	160
New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells	143
Totale	3.041

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	20	0	0	0	0	0	0	0	0	0	8	8	4
2021/2022	88	22	2	4	6	3	2	1	1	2	6	11	28
2022/2023	250	19	18	13	12	15	38	32	31	23	20	22	7
2023/2024	296	22	15	46	10	26	54	63	18	4	4	19	15
2024/2025	751	22	30	68	41	58	54	115	65	75	38	57	128
2025/2026	1.575	78	284	392	177	257	53	157	37	65	75	0	0
Totale													3.041